BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12764129)

  • 1. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
    Rogers RS; Horvath CM; Matunis MJ
    J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS proteins promote SUMO-1 conjugation to STAT1.
    Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
    Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
    Ohshima T; Shimotohno K
    J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.
    Kotaja N; Aittomäki S; Silvennoinen O; Palvimo JJ; Jänne OA
    Mol Endocrinol; 2000 Dec; 14(12):1986-2000. PubMed ID: 11117529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity.
    Wang J; Feng XH; Schwartz RJ
    J Biol Chem; 2004 Nov; 279(47):49091-8. PubMed ID: 15337742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat1 and SUMO modification.
    Song L; Bhattacharya S; Yunus AA; Lima CD; Schindler C
    Blood; 2006 Nov; 108(10):3237-44. PubMed ID: 16857984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are STATS arginine-methylated?
    Komyod W; Bauer UM; Heinrich PC; Haan S; Behrmann I
    J Biol Chem; 2005 Jun; 280(23):21700-5. PubMed ID: 15826948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Sp3 is silenced through SUMO modification by PIAS1.
    Sapetschnig A; Rischitor G; Braun H; Doll A; Schergaut M; Melchior F; Suske G
    EMBO J; 2002 Oct; 21(19):5206-15. PubMed ID: 12356736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.
    Lee JM; Kang HJ; Lee HR; Choi CY; Jang WJ; Ahn JH
    FEBS Lett; 2003 Dec; 555(2):322-8. PubMed ID: 14644436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Stat1-mediated gene activation by PIAS1.
    Liu B; Liao J; Rao X; Kushner SA; Chung CD; Chang DD; Shuai K
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10626-31. PubMed ID: 9724754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-1 conjugation selectively modulates STAT1-mediated gene responses.
    Ungureanu D; Vanhatupa S; Grönholm J; Palvimo JJ; Silvennoinen O
    Blood; 2005 Jul; 106(1):224-6. PubMed ID: 15761017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4.
    Arora T; Liu B; He H; Kim J; Murphy TL; Murphy KM; Modlin RL; Shuai K
    J Biol Chem; 2003 Jun; 278(24):21327-30. PubMed ID: 12716907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction.
    Liao J; Fu Y; Shuai K
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5267-72. PubMed ID: 10805787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity.
    Degerny C; Monte D; Beaudoin C; Jaffray E; Portois L; Hay RT; de Launoit Y; Baert JL
    J Biol Chem; 2005 Jul; 280(26):24330-8. PubMed ID: 15857832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation.
    Zheng G; Yang YC
    J Biol Chem; 2004 Oct; 279(41):42410-21. PubMed ID: 15280358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.